It is therefore unsurprising that pharmacological solutionsparticularly GLP-1 receptor agonistshave seen such rapid adoption
If you have any questions, ask your pharmacist or healthcare professional
More recently, novel formulations of double and triple gut hormone receptor agonists (involving glucose-dependent insulinotropic polypeptide [GIP] and glucagon) have been successfully developed [4], and other hormones, such as oestrogens and thyroid hormones, have also shown potential for use as therapies for the treatment of diabetes
This helps the pancreas release insulin in response to food, improves how the body processes fat, and sends appetite-reducing signals to brain regions that GLP-1-only drugs do not reach
Driving safety: Avoid driving when experiencing dizziness or symptoms of hypoglycaemia
stability comes with time